These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5082872)

  • 21. Drug treatment of hyperlipoproteinaemia.
    Romics L
    Ther Hung; 1983; 31(4):152-60. PubMed ID: 6400456
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of patients having suffered ischemic stroke with nicotinic acid and antichoagulants].
    Koniukhov SG; Liberzon SP
    Klin Med (Mosk); 1975 Sep; 53(9):38-41. PubMed ID: 1232494
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lipid reduction and myocardial infarct].
    Werkö L
    Lakartidningen; 1975 Apr; 72(15):1541-2. PubMed ID: 1134148
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experiences with vasoatherolip in early cerebral insufficiency].
    Wallerstein PV; Kronenwerth D
    Fortschr Med; 1976 May; 94(15):915-8. PubMed ID: 964843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical efficacy of nicergoline in cerebrovascular diseases. Statistical study].
    Guardamagna C; Negri S
    Minerva Cardioangiol; 1972 Nov; 20(11):636-41. PubMed ID: 4566130
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mental effects of Wallerox therapy in the aged].
    Thomae H
    Med Klin; 1970 Jun; 65(23):1132-4. PubMed ID: 5000216
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cerebrovascular disorders in severely sick patients--experience with Card Progresin].
    Osterloh U
    Z Allgemeinmed; 1971 Nov; 47(32):1709-12. PubMed ID: 5137904
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of cerebral vascular insufficiency].
    Hirsch W; Woschée G
    Ther Ggw; 1967 Sep; 106(9):1186-7 passim. PubMed ID: 5623071
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical experiences with gerontotherapeutic agent Wallerox (GN 468)].
    Voegt H; Haid E
    Med Klin; 1970 Nov; 65(46):2031-5. PubMed ID: 5000077
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ambulatory treatment of cerebrovascular disorders including encephalographic and ophthalmologic studies].
    Leube H; Schwaeppe C
    Med Monatsschr; 1970 Aug; 24(8):366-9. PubMed ID: 5515138
    [No Abstract]   [Full Text] [Related]  

  • 31. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of cerebral vasculopathies with a new pharmacologic combination].
    Gazzi A
    Policlinico Med; 1966 Feb; 73(1):39-47. PubMed ID: 5941604
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of Vascunicol on cerebrovascular disorders].
    Steinbach M
    Med Klin; 1970 Jun; 65(24):1175-7. PubMed ID: 4397085
    [No Abstract]   [Full Text] [Related]  

  • 34. [Possibilities of inspecting the action of drugs on the circulatory system].
    Gros C; Weill J; Vrousos C; Turpel A
    J Radiol Electrol Med Nucl; 1967; 48(1):97-8. PubMed ID: 6030146
    [No Abstract]   [Full Text] [Related]  

  • 35. [Arteriosclerosis--nicotinic acid therapy. 10. Combination therapy in hyperlipemia].
    Hansen PF
    Lakartidningen; 1971 Apr; 68(15):1769-72. PubMed ID: 5577252
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease.
    Rosenhamer G; Carlson LA
    Atherosclerosis; 1980 Sep; 37(1):129-42. PubMed ID: 7426081
    [No Abstract]   [Full Text] [Related]  

  • 37. Coronary drug project.
    JAMA; 1978 Sep; 240(14):1483-4. PubMed ID: 682349
    [No Abstract]   [Full Text] [Related]  

  • 38. [Arteriosclerosis--nicotinic acid therapy. 8. Treatment of hyperlipemia].
    Sigroth K
    Lakartidningen; 1971 Apr; 68(15):1765-7. PubMed ID: 5577250
    [No Abstract]   [Full Text] [Related]  

  • 39. [A new product acting on cerebral circulation: results of the use in neurosurgery of 7-(2 hydroxy-3-N-2-hydroxy-ethyl-N-methylamino propyl) 1-3 dimethylaxanthine pyridine-3-carboxyl or complamin].
    Pouyanne H; Guérin J; Maurin P
    J Med Bord; 1967 Nov; 114(11):1693-702. PubMed ID: 5602594
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experience with Cosaldon retard in double blind studies].
    Dreyer H; Keussen M; Wojtek L
    Dtsch Med J; 1969 May; 20(10):356-8. PubMed ID: 4919479
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.